4.56
전일 마감가:
$4.815
열려 있는:
$4.75
하루 거래량:
4.42M
Relative Volume:
1.04
시가총액:
$1.09B
수익:
$251.85M
순이익/손실:
$-72.58M
주가수익비율:
-14.55
EPS:
-0.3134
순현금흐름:
$-63.80M
1주 성능:
-0.22%
1개월 성능:
-11.11%
6개월 성능:
-22.45%
1년 성능:
-29.63%
Ardelyx Inc Stock (ARDX) Company Profile
명칭
Ardelyx Inc
전화
510-745-7047
주소
34175 ARDENWOOD BLVD., FREMONT, CA
ARDX을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
ARDX
Ardelyx Inc
|
4.56 | 1.09B | 251.85M | -72.58M | -63.80M | -0.3134 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
477.52 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
561.49 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
595.70 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
232.75 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
229.22 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-03-07 | 재개 | Ladenburg Thalmann | Buy |
2025-03-04 | 개시 | BTIG Research | Buy |
2024-11-11 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
2024-07-02 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
2024-04-05 | 개시 | Leerink Partners | Outperform |
2023-12-18 | 개시 | Raymond James | Strong Buy |
2023-09-07 | 개시 | H.C. Wainwright | Buy |
2023-08-25 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
2023-03-03 | 업그레이드 | Wedbush | Neutral → Outperform |
2022-11-17 | 업그레이드 | Piper Sandler | Neutral → Overweight |
2022-05-06 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
2021-12-01 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
2021-10-14 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
2021-07-21 | 다운그레이드 | Jefferies | Buy → Hold |
2021-07-20 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
2021-07-20 | 다운그레이드 | Wedbush | Outperform → Neutral |
2021-03-23 | 개시 | Wedbush | Outperform |
2021-01-06 | 개시 | Cantor Fitzgerald | Overweight |
2020-10-20 | 재개 | Citigroup | Buy |
2020-02-18 | 재개 | Jefferies | Buy |
2020-02-12 | 개시 | Citigroup | Buy |
2020-02-10 | 개시 | Cowen | Outperform |
2019-04-08 | 개시 | Piper Jaffray | Overweight |
2018-08-24 | 개시 | Jefferies | Buy |
2018-03-19 | 재개 | Leerink Partners | Outperform |
2017-11-29 | 재확인 | Citigroup | Buy |
2017-11-22 | 재확인 | Ladenburg Thalmann | Buy |
2017-10-17 | 재개 | Leerink Partners | Outperform |
2016-03-31 | 개시 | Ladenburg Thalmann | Buy |
2016-03-09 | 개시 | Cantor Fitzgerald | Buy |
2016-03-03 | 개시 | Citigroup | Buy |
모두보기
Ardelyx Inc 주식(ARDX)의 최신 뉴스
Press Release Distribution & PR Platform - ACCESS Newswire
Lobbying Update: $620,000 of ARDELYX INC. lobbying was just disclosed - Nasdaq
Ardelyx to Report First Quarter 2025 Financial Results on May 1, 2025 - The Manila Times
Ardelyx to Report First Quarter 2025 Financial Results on May 1, 2025 | ARDX Stock News - GuruFocus
Ardelyx, Inc. Schedules Conference Call to Discuss Q1 2025 Financial Results and Business Update - Nasdaq
Is Ardelyx Inc. (NASDAQ:ARDX) the Best Biotech Penny Stock to Buy According to Hedge Funds? - Insider Monkey
April 2025's Top Penny Stocks To Watch - Yahoo Finance
13 Best Biotech Penny Stocks to Buy According to Hedge Funds - Insider Monkey
Stride Announces Date for Third Quarter Fiscal Year 2025 Earnings Call - The Globe and Mail
Ardelyx reveals new findings on CKD treatment XPHOZAH at NKF event - Investing.com Canada
Ardelyx reveals new findings on CKD treatment XPHOZAH at NKF event By Investing.com - Investing.com South Africa
Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) to be Presented at the National Kidney Foundation Spring Clinical Meetings - The Manila Times
Ontario Teachers' Appoints Terry Hickey as Chief Technology Officer - The Globe and Mail
Class Action Filed Against Ardelyx, Inc. (ARDX) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire
ARDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ardelyx, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Ardelyx CEO Michael Raab sells $191k in stock - Investing.com
Ardelyx CEO Michael Raab sells $191k in stock By Investing.com - Investing.com UK
Ardelyx stock hits 52-week low at $4.29 amid challenges By Investing.com - Investing.com South Africa
Ardelyx stock hits 52-week low at $4.29 amid challenges - Investing.com Australia
How To Trade (ARDX) - news.stocktradersdaily.com
Levi's (LEVI) Reports Q1: Everything You Need To Know Ahead Of Earnings - The Globe and Mail
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 15, 2024 in Ardelyx, Inc. LawsuitARDX - ACCESS Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 15, 2024 in Ardelyx LawsuitARDX - ACCESS Newswire
Ardelyx to Share a Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) at the National Kidney Foundation Spring Clinical Meetings - The Manila Times
First-in-Class Kidney Disease Drug XPHOZAH Reveals Breakthrough Clinical Results - Stock Titan
Commit To Purchase Ardelyx At $4, Earn 20.5% Annualized Using Options - Nasdaq
Institutional owners may take dramatic actions as Ardelyx, Inc.'s (NASDAQ:ARDX) recent 6.4% drop adds to one-year losses - simplywall.st
How to Take Advantage of moves in (ARDX) - news.stocktradersdaily.com
Shareholders that lost money on Ardelyx, Inc.(ARDX) should contact Levi & Korsinsky about pending Class ActionARDX - ACCESS Newswire
Ardelyx Requests to Dismiss Class Action Filed by Investors - TradingView
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardelyx - Marketscreener.com
ARDELYX INC- The GF Score's 5 Key Aspects of Analysis - GuruFocus.com
Trading (ARDX) With Integrated Risk Controls - news.stocktradersdaily.com
Ardelyx honors inaugural Derek Forfang award winners By Investing.com - Investing.com Australia
Ardelyx at Barclays Conference: Pipeline Expansion and Revenue Growth - Investing.com
Ardelyx at Barclays Conference: Pipeline Expansion and Revenue Growth By Investing.com - Investing.com UK
Ardelyx honors inaugural Derek Forfang award winners - Investing.com India
Ardelyx Announces the First Recipients of Derek Forfang Patient Advocate Award - The Manila Times
Five Champions of Kidney Disease Advocacy Receive Groundbreaking Ardelyx Recognition - StockTitan
Insider Buying: David Mott Acquires Shares of Ardelyx Inc (ARDX) - GuruFocus.com
Piper Sandler maintains $8 target on Ardelyx shares amid uncertainty By Investing.com - Investing.com South Africa
Piper Sandler maintains $8 target on Ardelyx shares amid uncertainty - Investing.com India
8,020 Shares in Ardelyx, Inc. (NASDAQ:ARDX) Bought by SBI Securities Co. Ltd. - Defense World
Ardelyx at Leerink Global Healthcare Conference: Navigating Challenges and Opportunities By Investing.com - Investing.com South Africa
Ardelyx at Leerink Global Healthcare Conference: Navigating Challenges and Opportunities - Investing.com India
Ardelyx Inc (ARDX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):